It is primarily the control of transcription and post-transcriptional processing that are critical to the development and progression of sporadic neoplasias

References

• Bingle L, Singleton V, Bingle CD (2002)The putative ovarian tumour marker gene HE4 (WDC2) is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21: 2768–2773.
   PubMed Web of Science ®Google Scholar
• Blume SW, Jackson NL, Frost AR, Grizzle WE, Shcherbakov OD, Choi H, Meng Z (2010)Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES. Exp. Mol. Pathol. 88: 341–352.
   PubMed Web of Science ®Google Scholar
• Bovell LC, Putcha BDK, Samuel T, Manne U (2013). Clinical implications of miRNAs in cancer. Biotech. & Histochem. 88: 388–396.
   PubMed Web of Science ®Google Scholar
• Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR (1996)Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 56: 1237–1240.
   PubMed Web of Science ®Google Scholar
• Cho WC (2007)OncomiRNAs: the discovery and progress of miRNAs in cancers. Mol. Cancer 6: 60.
   PubMed Web of Science ®Google Scholar
• Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, Zeleniuch-Jacquotte A, Polsky D, Ferrara J, Perez-Soler R, Cordon-Cardo C, Pagano M, Osman, I (2003)Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin. Cancer Res. 9: 2613.
   PubMed Web of Science ®Google Scholar
• Durand G, Seta N (2000)Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin. Chem. 48: 795–805.
   Google Scholar
• Esquela-Kerscher A, Slack FJ (2006)OncomiRNAs - microRNAs with a role in cancer. Nat. Rev. Cancer. 64: 259–269.
   Google Scholar
• Frederick PJ, Green HN, Huang JS, Egger ME, Frieboes HB, Grizzle WE, McNally LR (2013) Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotech. & Histochem. 88: 403–409.
   PubMed Web of Science ®Google Scholar
• Grizzle WE (2009)Model of fixation. Biotech. & Histochem. 84: 185–193.
   PubMed Web of Science ®Google Scholar
• Grizzle WE, Srivastava S, Manne U (2012a)The biology of incipient, pre-invasive or intraepithelial neoplasia. In: Srivastava S, Grizzle WE, Eds. Translational Pathology of Early Cancer, IOS Press BV, Amsterdam. pp. 21–39.
   Google Scholar
• Grizzle WE, Srivastava S, Manne U (2012b)Translational pathology of cancer. In: Grizzle WE, Srivastava S, Eds. Translational Pathology of Early Cancer. IOS Press BV, Amsterdam. pp. 7–20.
   Google Scholar
• Huang JS, Egger ME, Grizzle WE, McNally LR (2013). MiRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells. Biotech. & Histochem. 88: 397–402.
   PubMed Web of Science ®Google Scholar
• Hurst DR, Edmonds MD, Welch DR (2009)Metastamir: the field of metastasis-regulatory miRNA is spreading. Cancer Res. 6919: 7495–7498.
   Google Scholar
• Jones J, Wang H, Grizzle W, Yates C (2013). MicroRNAs that contribute to aggressive prostate cancer: emphasis on African American prostate cancers. Biotech. & Histochem. 88: 373–387.
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschi T, Manoharan M, Stoffel M (2005)Silencing of miRNAs in vivo with ‘antagomiRNAs.‘. Nature 438 doi:10.1038/nature04303.
   PubMedGoogle Scholar
• Li M, Wang IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG (2011)Widespread RNA and DNA sequence differences in the human transcriptome. Science 333: 53–58.
   PubMed Web of Science ®Google Scholar
• Manne U, Shanmugam C, Katkoori VR, Grizzle WE (2012)Development and progression of colorectal neoplasia. In: Grizzle WE, Srivastava S, Eds., Translational Pathology of Early Cancer, IOS Press BV, Amsterdam. pp. 235–265.
   Google Scholar
• McNally LR, Manne U, Grizzle WE (2013). Post-transcriptional processing of genetic information and its relation to cancer. Biotech. & Histochem. 88: 365–372.
   PubMed Web of Science ®Google Scholar
• Moremen KW, Tiemeyer M, Nairn AV (2012)Protein N-glycosylation and quality control of protein folding. Nat. Rev. Molec. Cell Biol. 13: 448–462.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Grizzle WE (2012)Biomarkers and the genetics of early neoplastic lesions. In: Srivastava S, Grizzle WE, Eds., Translational Pathology of Early Cancer, IOS Press BV, Amsterdam. pp. 41–64.
   Google Scholar
• Srivastava SK, Bhardwau A, Leavesley SJ, Grizzle WE, Singh S, Singh AP (2013). MiRNAs as potential clinical biomarkers: emerging approaches for their detection. Biotech. & Histochem. 88: 373– 387.
   PubMed Web of Science ®Google Scholar
• Zhang H-G, Grizzle WE (2011)Exosomes and cancer: a newly described pathway of immune suppression. Clin. Cancer Res. 17: 959–64.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Grizzle WE (2013)The effects of exosomes and related vesicles on cancer development, progression and dissemination. In: Ed Zhang HG, Ed. Emerging Concepts of Tumor Exosomes-Mediated Cell-Cell Communication, Springer Science, New York. pp. 107–129.
   Google Scholar